nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A4—Temozolomide—malignant glioma	0.226	1	CbGbCtD
Ethosuximide—Cerebration impaired—Temozolomide—malignant glioma	0.0146	0.0562	CcSEcCtD
Ethosuximide—Paranoia—Carmustine—malignant glioma	0.0131	0.0502	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Temozolomide—malignant glioma	0.0116	0.0447	CcSEcCtD
Ethosuximide—Disturbance in attention—Temozolomide—malignant glioma	0.00993	0.0382	CcSEcCtD
Ethosuximide—Aplastic anaemia—Temozolomide—malignant glioma	0.00808	0.031	CcSEcCtD
Ethosuximide—Mental disability—Carmustine—malignant glioma	0.00773	0.0297	CcSEcCtD
Ethosuximide—Mental disability—Temozolomide—malignant glioma	0.00747	0.0287	CcSEcCtD
Ethosuximide—Ataxia—Carmustine—malignant glioma	0.00608	0.0234	CcSEcCtD
Ethosuximide—Ataxia—Temozolomide—malignant glioma	0.00587	0.0226	CcSEcCtD
Ethosuximide—Breast disorder—Temozolomide—malignant glioma	0.00565	0.0217	CcSEcCtD
Ethosuximide—Pancytopenia—Carmustine—malignant glioma	0.00531	0.0204	CcSEcCtD
Ethosuximide—Pancytopenia—Temozolomide—malignant glioma	0.00513	0.0197	CcSEcCtD
Ethosuximide—Weight decreased—Temozolomide—malignant glioma	0.00489	0.0188	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00477	0.0183	CcSEcCtD
Ethosuximide—Connective tissue disorder—Carmustine—malignant glioma	0.00439	0.0169	CcSEcCtD
Ethosuximide—Urinary tract disorder—Temozolomide—malignant glioma	0.00427	0.0164	CcSEcCtD
Ethosuximide—Connective tissue disorder—Temozolomide—malignant glioma	0.00425	0.0163	CcSEcCtD
Ethosuximide—Urethral disorder—Temozolomide—malignant glioma	0.00424	0.0163	CcSEcCtD
Ethosuximide—Eye disorder—Carmustine—malignant glioma	0.00418	0.0161	CcSEcCtD
Ethosuximide—Erythema multiforme—Temozolomide—malignant glioma	0.00409	0.0157	CcSEcCtD
Ethosuximide—Eye disorder—Temozolomide—malignant glioma	0.00404	0.0155	CcSEcCtD
Ethosuximide—Mental disorder—Carmustine—malignant glioma	0.00392	0.0151	CcSEcCtD
Ethosuximide—Immune system disorder—Temozolomide—malignant glioma	0.0039	0.015	CcSEcCtD
Ethosuximide—Mediastinal disorder—Temozolomide—malignant glioma	0.0039	0.015	CcSEcCtD
Ethosuximide—Malnutrition—Carmustine—malignant glioma	0.00389	0.015	CcSEcCtD
Ethosuximide—Mental disorder—Temozolomide—malignant glioma	0.00379	0.0145	CcSEcCtD
Ethosuximide—Malnutrition—Temozolomide—malignant glioma	0.00376	0.0145	CcSEcCtD
Ethosuximide—CYP3A43—Metapathway biotransformation—CYP2C18—malignant glioma	0.00363	0.00707	CbGpPWpGaD
Ethosuximide—Agitation—Carmustine—malignant glioma	0.00358	0.0137	CcSEcCtD
Ethosuximide—Leukopenia—Carmustine—malignant glioma	0.00348	0.0134	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00346	0.00674	CbGpPWpGaD
Ethosuximide—Agitation—Temozolomide—malignant glioma	0.00346	0.0133	CcSEcCtD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00345	0.0067	CbGpPWpGaD
Ethosuximide—CYP3A7—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0034	0.00662	CbGpPWpGaD
Ethosuximide—Leukopenia—Temozolomide—malignant glioma	0.00337	0.0129	CcSEcCtD
Ethosuximide—CACNA1G—NCAM signaling for neurite out-growth—PTPN11—malignant glioma	0.00326	0.00635	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00322	0.00627	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00322	0.00626	CbGpPWpGaD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00318	0.0122	CcSEcCtD
Ethosuximide—CYP2E1—Tryptophan metabolism—CYP2C18—malignant glioma	0.00309	0.00601	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—GDNF—malignant glioma	0.00306	0.00594	CbGpPWpGaD
Ethosuximide—CYP3A5—Irinotecan Pathway—APC—malignant glioma	0.00305	0.00594	CbGpPWpGaD
Ethosuximide—Anorexia—Carmustine—malignant glioma	0.00303	0.0116	CcSEcCtD
Ethosuximide—Nervous system disorder—Temozolomide—malignant glioma	0.00301	0.0116	CcSEcCtD
Ethosuximide—Skin disorder—Temozolomide—malignant glioma	0.00298	0.0115	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—GSTT1—malignant glioma	0.00298	0.0058	CbGpPWpGaD
Ethosuximide—Anorexia—Temozolomide—malignant glioma	0.00293	0.0112	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.00292	0.00568	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00288	0.0056	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00287	0.00559	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00284	0.00553	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00284	0.00552	CbGpPWpGaD
Ethosuximide—Somnolence—Carmustine—malignant glioma	0.00282	0.0109	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00279	0.00544	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—PTGS1—malignant glioma	0.00279	0.00543	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00279	0.00543	CbGpPWpGaD
Ethosuximide—Decreased appetite—Carmustine—malignant glioma	0.00276	0.0106	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00274	0.0105	CcSEcCtD
Ethosuximide—Somnolence—Temozolomide—malignant glioma	0.00273	0.0105	CcSEcCtD
Ethosuximide—Decreased appetite—Temozolomide—malignant glioma	0.00267	0.0103	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00265	0.0102	CcSEcCtD
Ethosuximide—Fatigue—Temozolomide—malignant glioma	0.00265	0.0102	CcSEcCtD
Ethosuximide—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00261	0.00509	CbGpPWpGaD
Ethosuximide—CACNA1G—NCAM signaling for neurite out-growth—RAF1—malignant glioma	0.00261	0.00507	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Carmustine—malignant glioma	0.0026	0.00998	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.00258	0.00503	CbGpPWpGaD
Ethosuximide—Abdominal pain—Carmustine—malignant glioma	0.00251	0.00965	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00251	0.00965	CcSEcCtD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.0025	0.00486	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00249	0.00485	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00246	0.00479	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00246	0.00478	CbGpPWpGaD
Ethosuximide—Urticaria—Temozolomide—malignant glioma	0.00244	0.00937	CcSEcCtD
Ethosuximide—Abdominal pain—Temozolomide—malignant glioma	0.00243	0.00932	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00237	0.00461	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Carmustine—malignant glioma	0.00234	0.00899	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00233	0.00454	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00233	0.00453	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00232	0.00451	CbGpPWpGaD
Ethosuximide—Asthenia—Carmustine—malignant glioma	0.00228	0.00876	CcSEcCtD
Ethosuximide—Hypersensitivity—Temozolomide—malignant glioma	0.00226	0.00869	CcSEcCtD
Ethosuximide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00221	0.0043	CbGpPWpGaD
Ethosuximide—Asthenia—Temozolomide—malignant glioma	0.0022	0.00846	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—GDNF—malignant glioma	0.00218	0.00424	CbGpPWpGaD
Ethosuximide—Diarrhoea—Carmustine—malignant glioma	0.00217	0.00835	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.00215	0.00418	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00212	0.00412	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0021	0.00409	CbGpPWpGaD
Ethosuximide—Dizziness—Carmustine—malignant glioma	0.0021	0.00807	CcSEcCtD
Ethosuximide—Diarrhoea—Temozolomide—malignant glioma	0.0021	0.00807	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—RTEL1—malignant glioma	0.00209	0.00406	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—GSTP1—malignant glioma	0.00207	0.00402	CbGpPWpGaD
Ethosuximide—CYP3A43—Metapathway biotransformation—GSTP1—malignant glioma	0.00204	0.00396	CbGpPWpGaD
Ethosuximide—Dizziness—Temozolomide—malignant glioma	0.00203	0.0078	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00202	0.00394	CbGpPWpGaD
Ethosuximide—Vomiting—Carmustine—malignant glioma	0.00202	0.00776	CcSEcCtD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00202	0.00393	CbGpPWpGaD
Ethosuximide—Rash—Carmustine—malignant glioma	0.002	0.0077	CcSEcCtD
Ethosuximide—Dermatitis—Carmustine—malignant glioma	0.002	0.00769	CcSEcCtD
Ethosuximide—Headache—Carmustine—malignant glioma	0.00199	0.00765	CcSEcCtD
Ethosuximide—Vomiting—Temozolomide—malignant glioma	0.00195	0.0075	CcSEcCtD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.00194	0.00378	CbGpPWpGaD
Ethosuximide—Rash—Temozolomide—malignant glioma	0.00194	0.00744	CcSEcCtD
Ethosuximide—Dermatitis—Temozolomide—malignant glioma	0.00193	0.00743	CcSEcCtD
Ethosuximide—Headache—Temozolomide—malignant glioma	0.00192	0.00739	CcSEcCtD
Ethosuximide—Nausea—Carmustine—malignant glioma	0.00189	0.00725	CcSEcCtD
Ethosuximide—Nausea—Temozolomide—malignant glioma	0.00182	0.00701	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—CYP2B6—malignant glioma	0.00171	0.00333	CbGpPWpGaD
Ethosuximide—CACNA1G—NCAM signaling for neurite out-growth—KRAS—malignant glioma	0.00169	0.00329	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP2B6—malignant glioma	0.00169	0.00328	CbGpPWpGaD
Ethosuximide—CYP2E1—Tryptophan metabolism—CAT—malignant glioma	0.00168	0.00328	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—SOX2—malignant glioma	0.00165	0.00321	CbGpPWpGaD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.00161	0.00312	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00153	0.00298	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00153	0.00298	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP2C18—malignant glioma	0.00148	0.00289	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP2C18—malignant glioma	0.00146	0.00285	CbGpPWpGaD
Ethosuximide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00145	0.00282	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00143	0.00279	CbGpPWpGaD
Ethosuximide—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.00142	0.00276	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00134	0.0026	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00132	0.00256	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—PTK2—malignant glioma	0.00131	0.00256	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2B6—malignant glioma	0.00124	0.00241	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2B6—malignant glioma	0.00124	0.00241	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00122	0.00238	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2B6—malignant glioma	0.00122	0.00237	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GSTT1—malignant glioma	0.0012	0.00234	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—COX8A—malignant glioma	0.0012	0.00233	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00116	0.00225	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00114	0.00222	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—PTGS1—malignant glioma	0.00112	0.00219	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—FGFR1—malignant glioma	0.0011	0.00214	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00108	0.00211	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2C18—malignant glioma	0.00107	0.00209	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.00107	0.00209	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00106	0.00206	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.00106	0.00206	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—KDR—malignant glioma	0.00103	0.00201	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ASMT—malignant glioma	0.00102	0.00198	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MET—malignant glioma	0.00101	0.00197	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BCAN—malignant glioma	0.000959	0.00187	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000939	0.00183	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PTK2—malignant glioma	0.000937	0.00182	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—PTPN11—malignant glioma	0.000936	0.00182	CbGpPWpGaD
Ethosuximide—CYP2E1—Tryptophan metabolism—MDM2—malignant glioma	0.00093	0.00181	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HES1—malignant glioma	0.000921	0.00179	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NCOR1—malignant glioma	0.000916	0.00178	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTT1—malignant glioma	0.000869	0.00169	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000868	0.00169	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MMP2—malignant glioma	0.000844	0.00164	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—RTEL1—malignant glioma	0.000841	0.00164	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.000832	0.00162	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.00082	0.0016	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—PTGS1—malignant glioma	0.000815	0.00158	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000813	0.00158	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—FGFR1—malignant glioma	0.000783	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000781	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—IDH2—malignant glioma	0.000773	0.0015	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—RAF1—malignant glioma	0.000748	0.00145	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—ERBB2—malignant glioma	0.00074	0.00144	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KDR—malignant glioma	0.000738	0.00144	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2B6—malignant glioma	0.000727	0.00141	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MET—malignant glioma	0.000722	0.00141	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000711	0.00138	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NOTCH1—malignant glioma	0.000695	0.00135	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000673	0.00131	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PTPN11—malignant glioma	0.000668	0.0013	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—IDH1—malignant glioma	0.000665	0.00129	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARG—malignant glioma	0.000656	0.00128	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SPHK1—malignant glioma	0.000643	0.00125	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MMP9—malignant glioma	0.000635	0.00123	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2C18—malignant glioma	0.00063	0.00123	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT2—malignant glioma	0.000622	0.00121	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000609	0.00119	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000608	0.00118	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.000603	0.00117	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP2—malignant glioma	0.000602	0.00117	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000601	0.00117	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.000594	0.00116	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000593	0.00115	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000575	0.00112	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—FGF2—malignant glioma	0.000572	0.00111	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—VEGFA—malignant glioma	0.00057	0.00111	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000567	0.0011	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—RAF1—malignant glioma	0.000534	0.00104	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—ERBB2—malignant glioma	0.000528	0.00103	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—EGFR—malignant glioma	0.000513	0.000998	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTT1—malignant glioma	0.00051	0.000991	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000499	0.00097	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000492	0.000957	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—KRAS—malignant glioma	0.000484	0.000942	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—COX8A—malignant glioma	0.000483	0.00094	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS1—malignant glioma	0.000477	0.000929	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP9—malignant glioma	0.000453	0.000881	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—BCHE—malignant glioma	0.000444	0.000864	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—SLC5A5—malignant glioma	0.000438	0.000853	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000431	0.00084	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ASMT—malignant glioma	0.000411	0.000799	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—malignant glioma	0.000407	0.000791	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000403	0.000785	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—STAT3—malignant glioma	0.000403	0.000783	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BCAN—malignant glioma	0.000386	0.000751	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000378	0.000735	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—EGFR—malignant glioma	0.000366	0.000712	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTP1—malignant glioma	0.000353	0.000687	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—COX8A—malignant glioma	0.00035	0.000681	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—COX8A—malignant glioma	0.000349	0.000679	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—malignant glioma	0.000348	0.000678	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KRAS—malignant glioma	0.000346	0.000673	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CAT—malignant glioma	0.000344	0.000669	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NCOR1—malignant glioma	0.000325	0.000632	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—IDH2—malignant glioma	0.000311	0.000606	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ASMT—malignant glioma	0.000298	0.000579	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ASMT—malignant glioma	0.000297	0.000578	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000293	0.000569	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000283	0.00055	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BCAN—malignant glioma	0.00028	0.000544	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.00028	0.000544	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BCAN—malignant glioma	0.000279	0.000543	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000276	0.000536	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—IDH1—malignant glioma	0.000268	0.000521	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CAV1—malignant glioma	0.000265	0.000515	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—malignant glioma	0.000259	0.000505	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000259	0.000504	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000254	0.000494	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CG—malignant glioma	0.000241	0.000469	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—malignant glioma	0.000233	0.000453	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—IDH2—malignant glioma	0.000225	0.000439	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—IDH2—malignant glioma	0.000225	0.000438	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2B6—malignant glioma	0.000212	0.000413	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CD—malignant glioma	0.000212	0.000412	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000212	0.000412	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000205	0.000399	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—IDH1—malignant glioma	0.000194	0.000377	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—IDH1—malignant glioma	0.000194	0.000377	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000192	0.000374	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SPHK1—malignant glioma	0.000188	0.000365	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000187	0.000364	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—malignant glioma	0.000185	0.000359	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2C18—malignant glioma	0.000184	0.000358	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000183	0.000357	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—malignant glioma	0.000183	0.000356	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—BCHE—malignant glioma	0.000179	0.000348	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000177	0.000344	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COX8A—malignant glioma	0.000162	0.000316	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—malignant glioma	0.00016	0.00031	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTT1—malignant glioma	0.000149	0.000289	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000148	0.000289	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000142	0.000277	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS1—malignant glioma	0.000139	0.000271	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000139	0.00027	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAT—malignant glioma	0.000138	0.000269	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ASMT—malignant glioma	0.000138	0.000269	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000131	0.000254	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BCAN—malignant glioma	0.00013	0.000253	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—BCHE—malignant glioma	0.00013	0.000252	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—BCHE—malignant glioma	0.000129	0.000251	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC5A5—malignant glioma	0.000128	0.000249	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC5A5—malignant glioma	0.000128	0.000248	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—malignant glioma	0.000113	0.000219	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAV1—malignant glioma	0.000107	0.000207	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—IDH2—malignant glioma	0.000105	0.000204	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTP1—malignant glioma	0.000103	0.000201	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTP1—malignant glioma	0.000103	0.0002	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAT—malignant glioma	0.0001	0.000195	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAT—malignant glioma	0.0001	0.000195	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.84e-05	0.000191	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—malignant glioma	9.71e-05	0.000189	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOR1—malignant glioma	9.47e-05	0.000184	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOR1—malignant glioma	9.45e-05	0.000184	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—malignant glioma	9.37e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—malignant glioma	9.2e-05	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—IDH1—malignant glioma	9e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SPHK1—malignant glioma	8.7e-05	0.000169	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—malignant glioma	8.53e-05	0.000166	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.53e-05	0.000166	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAV1—malignant glioma	7.72e-05	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAV1—malignant glioma	7.7e-05	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—malignant glioma	7.44e-05	0.000145	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—malignant glioma	7.37e-05	0.000143	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—malignant glioma	7.03e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.02e-05	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTT1—malignant glioma	6.9e-05	0.000134	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—malignant glioma	6.79e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—malignant glioma	6.77e-05	0.000132	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS1—malignant glioma	6.46e-05	0.000126	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—malignant glioma	6.43e-05	0.000125	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—malignant glioma	6.18e-05	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.17e-05	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BCHE—malignant glioma	6.01e-05	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.94e-05	0.000115	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—malignant glioma	5.39e-05	0.000105	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—malignant glioma	5.38e-05	0.000105	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—malignant glioma	5.34e-05	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—malignant glioma	5.33e-05	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTP1—malignant glioma	4.78e-05	9.3e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—malignant glioma	4.66e-05	9.06e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAT—malignant glioma	4.65e-05	9.05e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—malignant glioma	4.65e-05	9.04e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.53e-05	8.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOR1—malignant glioma	4.39e-05	8.55e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—malignant glioma	3.7e-05	7.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAV1—malignant glioma	3.58e-05	6.97e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—malignant glioma	3.28e-05	6.39e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.28e-05	6.38e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.26e-05	6.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—malignant glioma	3.15e-05	6.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.87e-05	5.58e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—malignant glioma	2.68e-05	5.22e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—malignant glioma	2.68e-05	5.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.5e-05	4.86e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—malignant glioma	2.48e-05	4.82e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—malignant glioma	2.16e-05	4.2e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.52e-05	2.96e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—malignant glioma	1.24e-05	2.42e-05	CbGpPWpGaD
